Phio Pharmaceuticals Corp (PHIO)

Jun 15, 2026

PHIO Q1 2026 Earnings: EPS Miss Widens as Clinical-Stage Biotech Continues R&D InvestmentEarnings Sentiment Score - newsline.com

Jun 15, 2026

Jun 11, 2026

PHIO Q1 2026 Earnings: Wider-than-Expected Loss as Clinical-Stage Biotech Reports ResultsProfit Inflection Point - newsline.com

Jun 11, 2026

Jun 10, 2026

Number of shareholders of Phio Pharmaceuticals Corp. – MUN:44R1 - TradingView

Jun 10, 2026

Jun 02, 2026

Phio Pharmaceuticals Q1 2026 Earnings: EPS Misses Estimates as R&D Spending IntensifiesEarnings Growth Forecast - newsline.com

Jun 02, 2026

May 29, 2026

Phio Pharmaceuticals Slides 2.6% as Selling Pressure PersistsForce Index - newsline.com

May 29, 2026

May 28, 2026

Phio Pharmaceuticals Q1 2026 Earnings: EPS Misses Estimates as Development-Stage Biotech Reports No Revenue - The Legal Advocate

May 28, 2026

May 28, 2026

Phio Pharmaceuticals Announces Participation in the Renmark Financial Communications Live Virtual Non-Deal Roadshow Series - TMX Newsfile

May 28, 2026

May 28, 2026

Phio Pharmaceuticals (PHIO) Edges Higher, Testing Key Resistance at $1.17Reversal Setup Alerts - newsline.com

May 28, 2026

May 27, 2026

Phio Pharmaceuticals Shares Tick Higher as CEO Hits the Road; Traders Eye Small Biotech - Bez Kabli

May 27, 2026

May 26, 2026

PHIO Q1 2026 Earnings: EPS Misses Estimates Amid Continued Clinical Trials FocusRevenue Beat Analysis - The Legal Advocate

May 26, 2026

May 26, 2026

Skin cancer treatment PH-762: Phio live Q&A session May 28 - Stock Titan

May 26, 2026

May 25, 2026

Phio Pharmaceuticals Holds Steady Near Support Levels; PHIO Stock Consolidates in Narrow RangeMA Cross Alert - The Legal Advocate

May 25, 2026

May 25, 2026

PHIO Q1 2026 Earnings: Wider-than-Expected Loss Reflects Ongoing R&D InvestmentInvestor Earnings Call - thelegaladvocate.com

May 25, 2026

May 24, 2026

PHIO Q1 2026 Earnings: EPS Misses Estimates as Research-Focused Biotech Maintains Development Pace - newsline.com

May 24, 2026

May 22, 2026

PHIO Stock Price, Quote & Chart | PHIO PHARMACEUTICALS CORP (NASDAQ:PHIO) - ChartMill

May 22, 2026

May 19, 2026

Phio Pharmaceuticals Announces "Innovations in Skin Cancer Treatment and Prevention" in a Fireside Chat with Force Family Office on Tuesday, May 19, 2026 - TMX Newsfile

May 19, 2026

May 16, 2026

Phio Pharmaceuticals (PHIO) Q1 2026 Results Miss Estimates — EPS $-0.34 vs $-0.24Product Mix - newser.com

May 16, 2026

May 15, 2026

Phio Pharmaceuticals Corp.Common Stock (NQ:PHIO) - FinancialContent

May 15, 2026

May 15, 2026

PHIO Should I Buy - Intellectia AI

May 15, 2026

May 13, 2026

TradingKey - TradingKey

May 13, 2026

May 12, 2026

Skin cancer drug hits 65% response; doctor, CEO to discuss what's next - Stock Titan

May 12, 2026

May 08, 2026

MSN Money - MSN

May 08, 2026

May 07, 2026

Why Phio Pharmaceuticals (PHIO) could be the turning point you've been waiting for (-0.87%) 2026-05-07Fast Rising Picks - newser.com

May 07, 2026

May 07, 2026

Phio Pharmaceuticals Corp. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com

May 07, 2026

May 07, 2026

Phio Pharmaceuticals (NASDAQ: PHIO) boosts PH-762 spending as Q1 2026 loss grows - Stock Titan

May 07, 2026

May 07, 2026

Phio Pharmaceuticals Reports First Quarter 2026 Financial Results and Business Update - TMX Newsfile

May 07, 2026

May 07, 2026

Skin cancer drug trial wraps at Phio, FDA submission targets Q2 - Stock Titan

May 07, 2026

May 06, 2026

PHIO Q1'26 Earnings: EPS estimate is (0.23) USD - TradingView

May 06, 2026

Apr 29, 2026

Is Phio Pharmaceuticals (PHIO) stock forming a trend channel | Q4 2025: EPS Tops ViewsStrategic Review - Newser

Apr 29, 2026

Apr 23, 2026

Cancer drug developer Phio sets April 29 live Q&A on clinical progress - Stock Titan

Apr 23, 2026

Apr 20, 2026

Phio Pharmaceuticals (PHIO) Stock Resistance Rejection (Modest Decline) 2026-04-20Expert Breakout Alerts - Cổng thông tin điện tử tỉnh Lào Cai

Apr 20, 2026

Apr 15, 2026

Phio Pharmaceuticals Announces "Nobel Prize Winning Science Takes on Skin Cancer" in a Fireside Chat with Force Family Office on Wednesday, April 15, 2026 - TMX Newsfile

Apr 15, 2026

Apr 14, 2026

Phio Pharmaceuticals Announces Presentation at Centri Capital Conference on April 14, 2026 - TMX Newsfile

Apr 14, 2026

Apr 14, 2026

PHIO: RNA immunotherapy shows strong tumor clearance and safety, advancing to next clinical phase - TradingView

Apr 14, 2026

Apr 13, 2026

Phio Pharmaceuticals to Discuss 'Nobel Prize Winning Science' for Skin Cancer Treatment - National Today

Apr 13, 2026

Apr 13, 2026

EPS Watch: Is Phio Pharmaceuticals Corp a stock for growth or value investors2026 Trade Ideas & Reliable Volume Spike Trade Alerts - baoquankhu1.vn

Apr 13, 2026

Apr 13, 2026

User - The Chronicle-Journal

Apr 13, 2026

Apr 13, 2026

How do market conditions affect Phio Pharmaceuticals (PHIO) Stock | Price at $1.24, Up 2.48%Demand Zone - newsline.com

Apr 13, 2026

Apr 11, 2026

Form 8-KCurrent report - ADVFN

Apr 11, 2026